Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

11.1%

2 terminated/withdrawn out of 18 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

56%

10 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
6(33.3%)
N/A
5(27.8%)
Phase 3
4(22.2%)
Phase 2
3(16.7%)
18Total
Phase 4(6)
N/A(5)
Phase 3(4)
Phase 2(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials
NCT06817096Phase 3Not Yet Recruiting

Efficacy and Safety of Nitazoxanide 600 Mg in the Outpatient Treatment of COVID-19 and Influenza

Role: collaborator

NCT06356012Phase 4Recruiting

Clinical Outcome and Biomarkers for Predicting Immunological Response in Patients Treated with Imiquimod

Role: collaborator

NCT05603403Phase 4Completed

Efficacy And Safety Of Probiatop In The Treatment Of Digestive Symptoms

Role: collaborator

NCT05945979Not ApplicableCompleted

Evaluation of the Efficacy of a New Supplement for Hair and Nails - in Vitro, Clinical, Subjective and Instrumental Study

Role: lead

NCT05879289Not ApplicableCompleted

Evaluation of the Effectiveness of the Anti-aging Effect of a Supplement in Improving Skin Conditions

Role: lead

NCT05530707Not ApplicableCompleted

Evaluation of Acceptability, Skin Barrier Restoration and Balance of Atopic Skin Using Moisturizer

Role: lead

NCT04423861Phase 3Unknown

Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19

Role: collaborator

NCT04441398Phase 2Withdrawn

Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 Patients

Role: collaborator

NCT04348409Not ApplicableCompleted

Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19

Role: collaborator

NCT04435314Phase 2Withdrawn

Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19

Role: collaborator

NCT03233412Phase 2Completed

Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial Lesions

Role: collaborator

NCT02592980Phase 4Unknown

Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients

Role: collaborator

NCT03782961Phase 4Unknown

Evaluation of Viscosity of a Vaginal Moisturizer

Role: lead

NCT03103958Not ApplicableCompleted

Effects of Probiotic on Modulation of the Intestinal Microbiota in Constipated Patients

Role: lead

NCT02987647Phase 4Unknown

Perception of Efficacy, Safety and Tolerability of Three Non-hormonal Intravaginal Gels and Hormone Cream

Role: lead

NCT02571127Phase 4Unknown

Evaluate the Efficacy, Safety and Tolerability of a Non-hormonal Intravaginal Gel in Postmenopausal Women With Symptoms of Vaginal Dryness.

Role: lead

NCT00980876Phase 3Completed

A Comparative Study Between Two Formulations of the Ciprofloxacin Hydrochloride + Hydrocortisone Otic Suspension

Role: lead

NCT01421433Phase 3Unknown

A Comparative Study Between Lysine Clonixinate+Cyclobenzaprine and Caffeine+Carisoprodol+Sodium Diclofenac+Paracetamol

Role: lead

All 18 trials loaded